Grace Therapeutics, Inc.
GRCENasdaqCIK 1444192HealthcareFiscal year ends Mar 31
Reports and events: 372 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-02-1208:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-013568 |
| 2024-02-1207:30 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0000950170-24-013566 |
| 2024-01-0807:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-002689 |
| 2023-12-1507:30 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0000950170-23-070574 |
| 2023-11-1308:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062474 |
| 2023-11-1307:30 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-062437 |
| 2023-10-2316:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-054637 |
| 2023-10-1116:30 ET | 8-K | 5.07 Shareholder vote results | 0000950170-23-052891 |
| 2023-09-2608:10 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-049796 |
| 2023-08-2516:15 ET | DEF 14A | Proxy statementPeriod 2023-10-10 | 0000950170-23-044579 |
| 2023-08-1107:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-041606 |
| 2023-08-1107:15 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-041595 |
| 2023-07-2417:30 ET | 8-K | 8.01 Other events | 0000950170-23-034113 |
| 2023-07-0708:30 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-032154 |
| 2023-07-0516:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-031612 |
| 2023-06-2307:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-029500 |
| 2023-06-2307:01 ET | 10-K | Annual reportPeriod 2023-03-31 | 0000950170-23-029498 |
| 2023-05-1116:50 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0000950170-23-021346 |
| 2023-04-0517:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-011938 |
| 2023-03-3116:39 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-23-011424 |
| 2023-03-1308:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-007448 |
| 2023-02-2318:15 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0000950170-23-003847 |
| 2023-02-1407:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-002698 |
| 2023-02-1407:00 ET | 10-Q | Quarterly reportPeriod 2022-12-31 | 0000950170-23-002695 |
| 2023-01-2516:10 ET | 8-K | 8.01 Other events | 0000950170-23-001174 |
| 2022-12-2808:10 ET | 8-K | 8.01 Other events | 0000950170-22-027060 |
| 2022-12-2208:17 ET | 8-K | 8.01 Other events | 0000950170-22-026910 |
| 2022-11-1407:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-024677 |
| 2022-11-1407:01 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-024666 |
| 2022-09-3016:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-22-019107 |
| 2022-09-2909:26 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-22-019002 |
| 2022-08-3107:00 ET | DEF 14A | Proxy statementPeriod 2022-09-28 | 0000950170-22-017938 |
| 2022-08-1107:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-016634 |
| 2022-08-1107:01 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-016632 |
| 2022-07-2917:27 ET | 10-K/A | Annual report, amendedPeriod 2022-03-31 | 0000950170-22-013526 |
| 2022-07-2917:01 ET | 8-K | 3.01 Delisting notice; 5.08 Item not in the standard list | 0000950170-22-013514 |
| 2022-06-2108:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-011843 |
| 2022-06-2108:08 ET | 10-K | Annual reportPeriod 2022-03-31 | 0000950170-22-011842 |
| 2022-05-1807:37 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-22-010232 |
| 2022-03-2507:36 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-22-004612 |
| 2022-02-1407:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-001151 |
| 2022-02-1406:30 ET | 10-Q | Quarterly reportPeriod 2021-12-31 | 0000950170-22-001147 |
| 2021-12-0207:17 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-21-008273 |
| 2021-11-1517:49 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-21-007887 |
| 2021-11-1007:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-21-007767 |
| 2021-11-1007:01 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001171843-21-007766 |
| 2021-11-0516:07 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001171843-21-007628 |
| 2021-09-2208:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-21-006589 |
| 2021-09-0916:19 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001171843-21-006408 |
| 2021-08-2708:47 ET | 8-K | 2.01 Completion of an acquisition or disposition; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-21-006192 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 18:09 ET. Listed shows no prices and gives no investment advice.